Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

EMT tumorigenesis in the mouse mammary gland.

Damonte P, Gregg JP, Borowsky AD, Keister BA, Cardiff RD.

Lab Invest. 2007 Dec;87(12):1218-26. Epub 2007 Oct 8.

3.

Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.

Gal A, Sjöblom T, Fedorova L, Imreh S, Beug H, Moustakas A.

Oncogene. 2008 Feb 21;27(9):1218-30. Epub 2007 Aug 27.

PMID:
17724470
4.

Epithelial-mesenchymal transition in mouse mammary tumorigenesis.

Radaelli E, Damonte P, Cardiff RD.

Future Oncol. 2009 Oct;5(8):1113-27. doi: 10.2217/fon.09.93. Review.

PMID:
19852725
5.

Mammary epithelial cells treated concurrently with TGF-alpha and TGF-beta exhibit enhanced proliferation and death.

Casey TM, Mulvey TM, Patnode TA, Dean A, Zakrzewska E, Plaut K.

Exp Biol Med (Maywood). 2007 Sep;232(8):1027-40.

PMID:
17720949
6.

NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.

Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T.

J Clin Invest. 2004 Aug;114(4):569-81.

7.

Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.

Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H, Grünert S.

J Cell Biol. 2002 Jan 21;156(2):299-313. Epub 2002 Jan 14.

8.

Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.

Lee YH, Albig AR, Regner M, Schiemann BJ, Schiemann WP.

Carcinogenesis. 2008 Dec;29(12):2243-51. doi: 10.1093/carcin/bgn199. Epub 2008 Aug 19.

9.

P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.

McHenry PR, Sears JC, Herrick MP, Chang P, Heckman-Stoddard BM, Rybarczyk M, Chodosh LA, Gunther EJ, Hilsenbeck SG, Rosen JM, Vargo-Gogola T.

Breast Cancer Res. 2010;12(5):R73. doi: 10.1186/bcr2643. Epub 2010 Sep 22.

10.

Expression of activated M-Ras in a murine mammary epithelial cell line induces epithelial-mesenchymal transition and tumorigenesis.

Ward KR, Zhang KX, Somasiri AM, Roskelley CD, Schrader JW.

Oncogene. 2004 Feb 12;23(6):1187-96. Erratum in: Oncogene. 2004 Nov 18;23(54):8858. Zhang, Kai-Xiu [corrected to Zhang, Kai-Xin].

PMID:
14961075
11.

The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.

Wang A, Arantes S, Yan L, Kiguchi K, McArthur MJ, Sahin A, Thames HD, Aldaz CM, Macleod MC.

BMC Cancer. 2008 Sep 22;8:268. doi: 10.1186/1471-2407-8-268.

12.

Decreased expression of glutaredoxin 1 is required for transforming growth factor-beta1-mediated epithelial-mesenchymal transition of EpRas mammary epithelial cells.

Lee EK, Jeon WK, Chae MY, Hong HY, Lee YS, Kim JH, Kwon JY, Kim BC, Park SH.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):1021-7. doi: 10.1016/j.bbrc.2009.12.009. Epub 2009 Dec 5.

PMID:
19968960
13.

The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner.

Serber DW, Rogala A, Makarem M, Rosson GB, Simin K, Godfrey V, Van Dyke T, Eaves CJ, Bultman SJ.

PLoS One. 2012;7(2):e31346. doi: 10.1371/journal.pone.0031346. Epub 2012 Feb 21.

14.

Irradiation of juvenile, but not adult, mammary gland increases stem cell self-renewal and estrogen receptor negative tumors.

Tang J, Fernandez-Garcia I, Vijayakumar S, Martinez-Ruis H, Illa-Bochaca I, Nguyen DH, Mao JH, Costes SV, Barcellos-Hoff MH.

Stem Cells. 2014 Mar;32(3):649-61. doi: 10.1002/stem.1533.

15.

Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.

Strizzi L, Bianco C, Normanno N, Seno M, Wechselberger C, Wallace-Jones B, Khan NI, Hirota M, Sun Y, Sanicola M, Salomon DS.

J Cell Physiol. 2004 Nov;201(2):266-76.

PMID:
15334661
16.

Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.

Oloumi A, Maidan M, Lock FE, Tearle H, McKinney S, Muller WJ, Aparicio SA, Dedhar S.

Breast Cancer Res. 2010;12(3):R38. doi: 10.1186/bcr2592. Epub 2010 Jun 21.

17.

Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.

Morini M, Astigiano S, Mora M, Ricotta C, Ferrari N, Mantero S, Levi G, Rossini M, Barbieri O.

Oncogene. 2000 Dec 7;19(52):6007-14.

18.

The pathology of EMT in mouse mammary tumorigenesis.

Cardiff RD.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):225-33. doi: 10.1007/s10911-010-9184-y. Epub 2010 Jun 4. Review.

19.

Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas.

Radaelli E, Arnold A, Papanikolaou A, Garcia-Fernandez RA, Mattiello S, Scanziani E, Cardiff RD.

Vet Pathol. 2009 Jul;46(4):736-45. doi: 10.1354/vp.08-VP-0280-R-FL. Epub 2009 Mar 9.

PMID:
19276050
20.

Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1.

di Bari MG, Ginsburg E, Plant J, Strizzi L, Salomon DS, Vonderhaar BK.

J Cell Physiol. 2009 Jun;219(3):659-66. doi: 10.1002/jcp.21712.

Supplemental Content

Support Center